University of Minnesota seeks participants for skin disease studyApril 5, 2019University of Minnesota (UMN) College of Veterinary Medicine is looking for candidates to enroll in an allergic skin disease study. The clinical trial will assess the safety and efficacy of a topical gel for dogs with atopic dermatitis (AD), which is a skin condition that causes severe itching and is hard to manage. According to the researchers, many of the current treatments produce unwanted side effects or they do not fully treat the symptoms. The study will last 14 days and will require the participants to visit UMN on day zero, seven, and 14. The dogs' owners will be required to use a topical gel on areas of their pets' skin and keep a medication diary throughout the duration. During the visits, Sheila Torres, DVM, MS, PhD, DACVD, will examine and assess the participants. Blood samples will be taken every visit and urine samples on day zero and 14. There is no cost, and at the end of the study dog owners will be eligible for to a $200 debit card. To participate dogs must: • have a short hair coat; • have red and inflamed skin, especially on their belly and/or paws; • have a …
SPONSORED CONTENTSee What the ACVIM Recommends for Certain Types of Canine CHFSafe, effective treatment that's approved by the FDA for management of certain types of canine CHF. + Learn More
Companies partner to perform trials of antimicrobial topical treatmentJanuary 9, 2019Stonehaven Incubate and antimicrobial protein specialist Lysando have agreed to jointly conduct proof-of-concept trials for new topical treatments based on Artilysin, a new antimicrobial platform technology.
Eli Global acquires veterinary derm company Stratford PharmaceuticalsAugust 28, 2018Eli Global LLC, based in Durham, N.C., has acquired Stratford Pharmaceuticals LLC, DBA Stratford Animal Health. Financial terms of the transaction were not disclosed. Stratford, which currently provides a wide arrangement of dermatology products to more than 10,000 veterinary hospitals in the U.S. and eight other countries, will continue to operate independently under the leadership of Brian Nugent, founder and CEO, from its Oldsmar, Fla., corporate headquarters. Greg Lindberg is chairman and CEO of Eli. "Partnering with Eli Global was a natural fit as it allows Stratford to keep our corporate identity, provide stability and continuity for our amazing employees while continuing to provide excellent products and services to our large base of veterinary hospitals in the U.S. and abroad," said Nugent. "In addition, Eli Global's resources include more than 100 businesses with 7,500-plus employees and over $20 Billion in proforma assets, which will allow Stratford to continue its double-digit organic growth while at the same time being extremely aggressive in the pursuit of animal health acquisitions."
The latest advancements in atopic dermatitis treatments in dogs and catsMay 10, 2016It’s no secret that one of the top conditions that compels people to take their pets to the veterinarian is itchy skin and the allergies that can cause it. Thankfully, treatment options for atopic dermatitis (AD) have improved greatly in recent years, and other solutions appear to be on the way.
